Literature DB >> 28546367

Intensive Versus Minimal Standard Dosage for Peritoneal Dialysis in Acute Kidney Injury: A Randomized Pilot Study.

Watanyu Parapiboon1, Treechada Jamratpan2.   

Abstract

BACKGROUND: Dosage for peritoneal dialysis (PD) in acute kidney injury (AKI) is controversial. This study aims to find benefits and risks of intensive versus minimal standard dosage of PD in AKI.
METHODS: In a tertiary-hospital, 93 AKI patients who required PD between May 2015 and January 2016 were enrolled in a randomized, open-label controlled study. Patients were randomized to intensive group (> 30 L) and minimal standard group (< 20 L) of PD volume per day for the first 2 consecutive days. The primary outcome was in-hospital mortality. The secondary outcomes were peritonitis rate, dialysis dependence, and PD leakage.
RESULTS: Seventy-five patients were analyzed (intensive PD n = 39; minimal standard PD n = 36). Mean age was 60 years. Most patients were in critical care (72% unstable hemodynamic, mean APACHE II score 26.2). Kt/V delivery per session was 0.61 and 0.38 in intensive and minimal standard PD dosage for the first 2 consecutive sessions. According to intention-to-treat analysis, the in-hospital mortality rate of intensive PD dosage was not significantly different from the minimal standard PD dosage (79% vs 63%, relative risk [RR] 1.11, 95% confidence interval [CI] 0.80 to 1.51, p = 0.13). The dialysis dependence rate and PD leakage were not significantly different between the 2 groups. The rate of PD peritonitis was slightly higher in the intensive PD dosage group (15.3% vs 8.3%, p = 0.34).
CONCLUSION: Among AKI patients who required PD, there was no significant difference in in-hospital mortality between intensive and minimal standard PD dosage.
Copyright © 2017 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  AKI; dosage of PD; mortality; peritoneal dialysis; randomized controlled trial

Mesh:

Year:  2017        PMID: 28546367     DOI: 10.3747/pdi.2016.00260

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  4 in total

1.  Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality.

Authors:  Naya Huang; Huiyan Li; Li Fan; Qian Zhou; Dongying Fu; Lin Guo; Chunyan Yi; Xueqing Yu; Haiping Mao
Journal:  Front Med (Lausanne)       Date:  2021-12-01

Review 2.  [Innovations in peritoneal dialysis].

Authors:  R Hausinger; C Schmaderer; U Heemann; Q Bachmann
Journal:  Nephrologe       Date:  2021-11-12

3.  Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury.

Authors:  Daniela Ponce; André L Balbi; Jonathan B Durand; Gustavo Moretta; José C Divino-Filho
Journal:  Clin Kidney J       Date:  2020-06-30

4.  Vancomycin Removal During High-Volume Peritoneal Dialysis in Acute Kidney Injury Patients: A Prospective Cohort Clinical Study.

Authors:  Daniela Ponce; Welder Zamoner; Fernanda Moreira Freitas; André Balbi; Linda Awdishu
Journal:  Kidney Int Rep       Date:  2018-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.